Benefits of SBRT for Metastatic Breast Cancer

Breast cancer is known universally to be one of the most common diagnoses for American women today, but what many may be unaware of is the potential for recurring or metastatic breast cancer.

The American Cancer Society estimates that more than 200,000 women will be diagnosed with invasive breast cancer this year. In some cases, women discover their breast cancer after experiencing symptoms, meaning there’s a possibility that the cancer may have advanced and spread to other vital organs in the body. One of the most common sites of breast cancer metastasis is to the lungs, liver or brain. Metastatic lesions that develop in another area of the body will require decisions about additional treatment options

Illinois CyberKnife offers an option to treat metastatic lesions that develop from the spread of breast cancer using an outpatient treatment called stereotactic body radiation therapy (SBRT). Using CyberKnife® technology, tumors and lesions are treated noninvasively with high-dose radiation. Patients experience few to no side effects, a key advantage for breast cancer patients who may have recently undergone chemotherapy for their primary tumor.

Treatment is complete in five or fewer sessions and patients can return to their normal routines following each session.

This is not intended as medical advice to replace the expertise and judgment of your health care team. It is intended to help you and your family make informed decisions, together with your doctor.